Evidence map›Paper›PMID 40302083›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Antioxidant and Anticancer Activities of Bio-Synthesized Selenium Nanoparticles by Escherichia coli.

Rasha Muhsin Yasir, Neihaya Heikmat Zaki

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rasha Muhsin YasirDepartment of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq.ORCID 0009-0009-1471-987X
Neihaya Heikmat ZakiDepartment of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq.ORCID 0000-0002-9619-6559

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSelenium, an essential micronutrient, plays a crucial role in various physiological processes, including immune function, fertility, and the prevention of chronic diseases like diabetes, cardiovascular disease, and certain cancers. While selenium nanoparticles (SeNPs) have garnered significant attention for their potential in cancer therapy, their biosynthesis using eco-friendly methods remains a key area of research.

methodsIn this study, Escherichia coli isolates were utilized to biosynthesize SeNPs from sodium selenite (25, 50, and 100 mM) at pH 8 and 160 rpm for 48 hours. The biosynthesized  SeNPs were characterized using Fourier Transform Infrared Spectroscopy (FTIR), UV-Visible spectroscopy, X-ray Diffraction (XRD), Scanning Electron Microscopy (SEM), and Atomic Force Microscopy (AFM). The antioxidant and anti-proliferative activities of the synthesized SeNPs were evaluated against human colorectal carcinoma (SW480), human hepatocellular carcinoma (HepG2), and normal human embryonic kidney (HEK293) cell lines.

resultsThe biosynthesis process resulted in a reddish-brown coloration of the medium, indicating the formation of SeNPs. Characterization techniques confirmed the successful synthesis of SeNPs with a size range of 21.96-50.71 nm. The SeNPs exhibited significant antioxidant activity, with a maximum radical scavenging efficiency of 80.21% at a concentration of 100 µg/ml. Additionally, the SeNPs demonstrated potent anti-proliferative effects against both SW480 and HepG2 cell lines, with IC50 values of 3.9 and 4.5 µg/ml, respectively. Importantly, the SeNPs exhibited negligible cytotoxicity towards normal HEK293 cells.

conclusionThe eco-friendly biosynthesis of SeNPs using E. coli offers a promising approach for producing nanoparticles with potential applications in biomedical fields. The synthesized SeNPs demonstrated potent antioxidant and anti-cancer properties, suggesting their potential as a novel therapeutic agent.

Indexed as

Antineoplastic AgentsAntioxidantsEscherichia coliMetal NanoparticlesNanoparticlesSeleniumCell ProliferationHep G2 CellsHumansAntineoplastic AgentsAntioxidantsSeleniumAnticancerAntioxidantBiosynthesisEscherichia coliSelenium Nanoparticles

Identifiers

PMID40302083
PMCPMC12227980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.